Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A …

R Garg, BP Mohan, R Krishnamoorthi… - Indian Journal of …, 2018 - Springer
Introduction Previous studies have reported that peri-procedural administration of rectal
indomethacin reduces the risk of pancreatitis in patients undergoing endoscopic retrograde …

[HTML][HTML] Rectal indomethacin is protective against pancreatitis after endoscopic retrograde cholangiopancreatography: systematic review and meta-analysis

X He, W Zheng, Y Ding, X Tang, J Si… - … Research and Practice, 2018 - hindawi.com
Background and Aim. Rectal indomethacin was reported to be effective for postendoscopic
retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) prophylaxis. However, the …

Rectal indomethacin prevents moderate to severe post-ERCP pancreatitis and death and should be used before the procedure: a meta-analysis of aggregate …

M Yaghoobi, MA Alzahrani… - Journal of the …, 2018 - academic.oup.com
Background Despite overall evidence in the literature favoring rectal indomethacin in
preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis …

Prophylactic rectal indomethacin may be ineffective for preventing post‐endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta …

Y Feng, U Navaneethan, X Zhu… - Digestive …, 2017 - Wiley Online Library
Background and Aim Efficacy of prophylactic indomethacin for prevention of post‐
endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in general …

Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients

JM Levenick, SR Gordon, LL Fadden, LC Levy… - Gastroenterology, 2016 - Elsevier
Background & Aims Rectal indomethacin, a nonsteroidal anti-inflammatory drug, is given to
prevent pancreatitis in high-risk patients undergoing endoscopic retrograde …

[HTML][HTML] How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis

J Wan, Y Ren, Z Zhu, L Xia, N Lu - BMC gastroenterology, 2017 - Springer
Background Acute pancreatitis is a severe complication of endoscopic retrograde
cholangiopancreatography (ERCP). Previous meta-analyses have shown that indomethacin …

The effect of indomethacin in the prevention of post–endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis

D Ahmad, KT Lopez, MA Esmadi, G Oroszi… - Pancreas, 2014 - journals.lww.com
Objectives Acute pancreatitis after endoscopic retrograde cholangiopancreatography
(ERCP) is a severe complication with substantial morbidity and mortality. Indomethacin has …

[PDF][PDF] Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials

N Shi, L Deng, K Altaf, W Huang, P Xue… - Turk J …, 2015 - turkjgastroenterol.org
ABSTRACT Background/Aims: This meta-analysis was undertaken to evaluate the effect of
rectal indomethacin in the prevention of post-endoscopic retrograde …

[HTML][HTML] A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde …

JH Lai, CY Hung, CH Chu, CJ Chen, HH Lin, HJ Lin… - Medicine, 2019 - journals.lww.com
Methods: We enrolled patients who underwent the ERCP in Taipei Mackay Memorial
Hospital from 2016 June to 2017 November. Patients were randomly assigned to 2 groups …

[HTML][HTML] Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients

MM Abdelfatah, E Gochanour, NJ Koutlas… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background: Evidence shows that rectal indomethacin (RI) reduces the risk of post-
endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk …